PDCD1 and neoplasm: The authors also demonstrated that T cell receptor (TCR) clonality positively correlated with both treatment response and with pre-treatment immune scores (used to estimate immune activation, within the tumor microenvironment), with regards to PD-1, but not to CTLA-4, blockade [67].